cox 189 has been researched along with sulbactam in 1 studies
| Studies (cox 189) | Trials (cox 189) | Recent Studies (post-2010) (cox 189) | Studies (sulbactam) | Trials (sulbactam) | Recent Studies (post-2010) (sulbactam) |
|---|---|---|---|---|---|
| 163 | 49 | 47 | 1,844 | 297 | 488 |
| Protein | Taxonomy | cox 189 (IC50) | sulbactam (IC50) |
|---|---|---|---|
| Beta-lactamase | Escherichia coli | 6.2 | |
| Beta-lactamase | Shouchella clausii | 0.075 | |
| Beta-lactamase | Pseudomonas aeruginosa | 0.37 | |
| Beta-lactamase | Pseudomonas aeruginosa | 3 | |
| Beta-lactamase | Aeromonas allosaccharophila | 4 | |
| Beta-lactamase | Staphylococcus aureus | 6.5 | |
| Beta-lactamase | Enterobacter cloacae | 1.4 | |
| Beta-lactamase TEM | Escherichia coli | 4.3 | |
| Beta-lactamase | Acinetobacter pittii | 1.12 | |
| Beta-lactamase | Acinetobacter pittii | 7.758 | |
| Beta-lactamase | Pseudomonas aeruginosa | 3 | |
| Beta-lactamase | Escherichia coli | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
1 other study(ies) available for cox 189 and sulbactam
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |